What is the appropriate emergency management for an anaphylactoid reaction in adults and children?

Emergency Management of Anaphylactoid Reactions

Immediately administer intramuscular epinephrine 0.3-0.5 mg (1:1000) into the anterolateral thigh as first-line treatment for any patient with signs of systemic allergic reaction, especially hypotension, airway swelling, or difficulty breathing. 1

Immediate Management Algorithm

First-Line Treatment: Epinephrine

Adults:

• Intramuscular (IM) route preferred: 0.2-0.5 mg of 1:1000 solution (0.3 mg standard dose) into anterolateral thigh
• Repeat every 5-15 minutes as needed 1
• IM injection into the lateral thigh produces rapid peak plasma concentrations and is safer than IV bolus 1

Children:

• >12 years: 0.5 mg IM (0.3 mg if small child) 2
• 6-12 years: 0.3 mg IM 2
• <6 years: 0.15 mg IM 2
• Pediatric autoinjector delivers 0.15 mg; adult autoinjector delivers 0.3 mg 1

Concurrent Immediate Actions

1. ABC approach - Airway, Breathing, Circulation 2
2. Remove causative agent immediately (stop IV infusions, remove latex, etc.) 2
3. Call for help 2
4. Position patient: Elevate legs if hypotensive 2
5. Administer 100% oxygen - intubate if necessary 2
6. Establish IV access and give rapid crystalloid bolus (normal saline or lactated Ringer's) - large volumes may be required 2

When to Use IV Epinephrine

For anaphylactic shock with IV access already in place:

• Adults: 0.05-0.1 mg IV (1:10,000 solution) - this is 5-10% of cardiac arrest dose 1
• Children: 0.01 mg/kg IV (0.1 mL/kg of 1:10,000 solution; maximum 0.3 mg) 3
• Titrate carefully to avoid arrhythmias 3

For refractory hypotension after multiple IM doses:

• Start epinephrine infusion at 5-15 μg/min, titrated to response 1
• Continuous hemodynamic monitoring is essential 1

Critical caveat: IV epinephrine carries significant arrhythmia risk and should only be used when IM epinephrine has failed or in profound shock with existing IV access 3. The 2020 AHA guidelines emphasize IM remains the preferred initial route 1.

Secondary Management

After epinephrine administration:

Adults:

• H1-antihistamine: Diphenhydramine 25-50 mg IV 3
• H2-antihistamine: Ranitidine 50 mg IV over 5 minutes (superior when combined with H1-blocker) 3
• Corticosteroids: Hydrocortisone 200 mg IV or methylprednisolone 1-2 mg/kg/day 2

Children:

• Diphenhydramine: 1-2 mg/kg IV 3
• Ranitidine: 1 mg/kg IV 3
• Corticosteroids: Methylprednisolone 1-2 mg/kg/day IV 3

Important Evidence-Based Limitations

Antihistamines and corticosteroids are second-line adjuncts only - they have slower onset than epinephrine and should never be used alone or delay epinephrine administration 3. The 2020 AHA guidelines explicitly state there is no proven benefit from antihistamines, inhaled beta-agonists, or IV corticosteroids during anaphylaxis-induced cardiac arrest 1.

Management of Specific Complications

Persistent Bronchospasm

• Nebulized albuterol 2.5-5 mg in 3 mL saline, repeat as needed 3
• Consider nebulized epinephrine 2
• Alternative: IV salbutamol infusion, aminophylline, or magnesium sulfate 2

Refractory Hypotension

• Aggressive IV fluid resuscitation 1
• Dopamine infusion 2-20 μg/kg/min if unresponsive to epinephrine and fluids 3
• Consider alternative vasopressors (e.g., metaraminol) 2

Beta-Blocker Complication

• Glucagon 1-5 mg IV over 5 minutes, followed by infusion at 5-15 μg/min 3
• Pediatric dose: 20-30 μg/kg (maximum 1 mg) 3
• Monitor for nausea/vomiting (aspiration risk) 3

Airway Obstruction

• Immediate advanced airway management with expert capable of surgical airway 1
• Emergency cricothyroidotomy or tracheostomy may be required for laryngeal edema 1

Cardiac Arrest Management

If cardiac arrest occurs:

• Standard BLS/ACLS protocols take priority 1
• High-dose IV epinephrine: Progress rapidly to 1-3 mg IV (1:10,000) over 3 minutes, then 3-5 mg, then 4-10 mg/min infusion 3
• Pediatric: 0.01 mg/kg (0.1 mL/kg of 1:10,000; max 0.3 mg) every 3-5 minutes 3

Monitoring and Disposition

Close Hemodynamic Monitoring Required

• Cardiovascular and respiratory status can deteriorate rapidly 1
• Monitor continuously during and after treatment 1

Laboratory Testing

Obtain mast cell tryptase levels (5-10 mL clotted blood) at three time points 2:

1. As soon as feasible after resuscitation starts (don't delay treatment)
2. At 1-2 hours after symptom onset
3. At 24 hours or in convalescence (baseline level)

Disposition

• Transfer to critical care for severe reactions 2
• Observation period: Consider biphasic reactions (recurrence 1-72 hours later occurs in <1-20% of cases) 4
• Discharge with epinephrine auto-injector and emergency action plan 4
• Mandatory specialist follow-up for trigger identification and risk reduction 5

Common Pitfalls to Avoid

1. Delaying epinephrine while giving antihistamines or steroids first - epinephrine is lifesaving and must be given immediately 1
2. Using IV epinephrine as first-line - IM is safer and preferred initially 1
3. Underdosing epinephrine - many patients require multiple doses 1
4. Failing to monitor after apparent recovery - biphasic reactions can occur 4
5. Not prescribing auto-injector at discharge - essential for future episodes 4